KẾT QUẢ ĐIỀU TRỊ NHIỄM TRÙNG ĐƯỜNG MẬT DO SỎI ỐNG MẬT CHỦ BẰNG NỘI SOI MẬT TỤY NGƯỢC DÒNG TẠI BỆNH VIỆN BẠCH MAI NĂM 2024-2025

Abstract

Objective: This study was conducted to evaluate the treatment outcomes of patients with cholangitis caused by common bile duct (CBD) stones managed by endoscopic retrograde cholangiopancreatography (ERCP) at Bach Mai Hospital during the period of 2024–2025. Methods: A descriptive cross-sectional study with both retrospective and prospective data collection was conducted on 125 inpatients diagnosed with cholangitis due to CBD stones. The study took place at the Department of Gastroenterology and Hepatology, Bach Mai Hospital, from August 2024 to May 2025. The results: Post-intervention laboratory markers significantly improved, including reductions in white blood cell count, C-reactive protein (CRP), total bilirubin, and liver enzymes (AST, ALT), with statistically significant differences (p < 0.01). The success rate of papillary cannulation was 97.6%; complete stone removal was achieved in 88.5% of cases, and partial removal in 8.2%. Biliary stenting was performed in 45.1% of patients. The complication rates following ERCP were: post-ERCP bleeding (4.1%), acute pancreatitis (1.6%), and no cases of duodenal perforation were reported. The rate of good clinical outcomes at discharge was 81.6%. Conclusion: ERCP is a safe and effective therapeutic modality for the management of cholangitis due to common bile duct stones.